Jane Street Group, LLC Neurocrine Biosciences Inc Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $15.4 Million - $20.6 Million	134,700 New	134,700 $15.5 Million
Q1 2022 May 17, 2022	SELL	$72.45 - $94.81 $2.35 Million - $3.07 Million	-32,400 Reduced 22.72%	110,200 $10.3 Million
Q4 2021 Feb 15, 2022	BUY	$79.65 - $106.22 $5.02 Million - $6.69 Million	63,000 Added 79.15%	142,600 $12.1 Million
Q3 2021 Nov 16, 2021	BUY	$86.18 - $99.03 $103,416 - $118,836	1,200 Added 1.53%	79,600 $7.63 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $321,948 - $368,172	3,600 Added 4.81%	78,400 $7.63 Million
Q1 2021 May 18, 2021	BUY	$87.57 - $119.4 $3.25 Million - $4.43 Million	37,100 Added 98.41%	74,800 $7.27 Million
Q4 2020 Feb 17, 2021	SELL	$86.91 - $108.33 $1.71 Million - $2.13 Million	-19,700 Reduced 34.32%	37,700 $3.61 Million
Q3 2020 Nov 17, 2020	BUY	$96.16 - $135.15 $1.36 Million - $1.91 Million	14,100 Added 32.56%	57,400 $5.52 Million
Q2 2020 Aug 17, 2020	BUY	$85.09 - $130.36 $1.63 Million - $2.5 Million	19,200 Added 79.67%	43,300 $5.28 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $525,770 - $796,320	7,000 Added 40.94%	24,100 $2.09 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $1.22 Million - $1.66 Million	14,000 Added 451.61%	17,100 $1.84 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $511,301 - $619,150	-6,100 Reduced 66.3%	3,100 $279,000
Q2 2019 Aug 15, 2019	BUY	$72.24 - $91.27 $267,288 - $337,699	3,700 Added 67.27%	9,200 $777,000
Q1 2019 May 16, 2019	BUY	$69.31 - $91.53 $221,792 - $292,896	3,200 Added 139.13%	5,500 $485,000
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $9,888 - $12,585	100 Added 4.55%	2,300 $283,000
Q2 2018 Aug 15, 2018	BUY	$75.3 - $105.99 $165,660 - $233,178	2,200 New	2,200 $216,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.35 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$697 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$349 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$252 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account